BIOGEN INC. Logo

BIOGEN INC.

Biotechnology company developing therapies for neurological and neurodegenerative diseases.

BIIB | US

Overview

Corporate Details

ISIN(s):
US09062X1037
LEI:
Country:
United States of America
Address:
225 BINNEY STREET, 2142 CAMBRIDGE

Description

Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people with serious neurological and neurodegenerative diseases. Founded in 1978, the company leverages cutting-edge science to address complex and hard-to-treat conditions. Its core therapeutic areas include multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and amyotrophic lateral sclerosis. In addition to its portfolio of novel drugs, Biogen also develops and commercializes biosimilars. The company's pipeline is concentrated on potential breakthrough treatments in neurology, immunology, and rare diseases, aiming to address significant unmet medical needs and improve patient outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-12 18:45
8-K
English 280.1 KB
2025-05-08 11:07
424B2
English 289.2 KB
2025-05-06 19:26
FWP
English 11.4 KB
2025-05-06 10:54
424B2
English 233.2 KB
2025-05-05 18:19
PRIMARY DOCUMENT
English 7.1 KB
2025-05-05 18:17
PRIMARY DOCUMENT
English 6.5 KB
2025-05-01 19:21
S-3ASR
English 342.9 KB
2025-05-01 18:48
10-Q
English 3.9 MB
2025-05-01 08:52
8-K
English 171.8 KB
2025-04-25 23:42
ARS
English 6.8 MB
2025-04-25 23:40
DEFA14A
English 1.1 MB
2025-04-25 23:38
DEF 14A
English 7.8 MB
2025-04-17 11:35 English 12.8 KB
2025-04-03 18:15
PRIMARY DOCUMENT
English 7.1 KB
2025-03-10 17:09
PRIMARY DOCUMENT
English 6.6 KB

Automate Your Workflow. Get a real-time feed of all BIOGEN INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOGEN INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOGEN INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.